Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
|
|
Acer Therapeutics Inc. (ACER)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
4
| Quartel Adrian W (Chief Medical Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.67, valued at
$50.1k
|
|
| 03/16/2023 |
4
| Paul Bernard H (Chief People Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.67, valued at
$50.1k
|
|
| 03/16/2023 |
4
| PALMIN HARRY S (CFO) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.67, valued at
$50.1k
|
|
| 03/16/2023 |
4
| Klopp John Michael (Chief Technical Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.67, valued at
$50.1k
|
|
| 03/16/2023 |
4
| Joseph Donald (Chief Legal Officer and Secy) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.67, valued at
$50.1k
|
|
| 03/16/2023 |
4
| Hayden Tanya (COO) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.67, valued at
$50.1k
|
|
| 03/16/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.67, valued at
$33.4k
|
|
| 03/16/2023 |
4
| DUNN JOHN MICHAEL (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.67, valued at
$33.4k
|
|
| 03/16/2023 |
4
| Davis Jefferson E (Chief Business Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.67, valued at
$50.1k
|
|
| 03/16/2023 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.67, valued at
$33.4k
|
|
| 03/16/2023 |
4
| Amello Jason (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.67, valued at
$33.4k
|
|
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Hayden Tanya (COO) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.76, valued at
$44k
|
|
| 02/23/2022 |
4
| Quartel Adrian W (Chief Medical Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 200,000 options to buy
@ $2.55, valued at
$510k
|
|
| 01/21/2022 |
4
| Paul Bernard H (Chief People Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.21, valued at
$55.3k
|
|
| 01/19/2022 |
4
| Seibt Matthew (Chief Commercial Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.21, valued at
$55.3k
|
|
| 01/19/2022 |
4
| Schelling Chris (President & CEO) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.21, valued at
$110.5k
|
|
| 01/19/2022 |
4
| PALMIN HARRY S (Chief Opp. and Financial Offr) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.21, valued at
$55.3k
|
|
| 01/19/2022 |
4
| Klopp John Michael (Chief Technical Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.21, valued at
$55.3k
|
|
| 01/19/2022 |
4
| Joseph Donald (Chief Legal Officer and Secy) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.21, valued at
$55.3k
|
|
| 01/19/2022 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 18,500 options to buy
@ $2.21, valued at
$40.9k
|
|
| 01/19/2022 |
4
| DUNN JOHN MICHAEL (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 18,500 options to buy
@ $2.21, valued at
$40.9k
|
|
| 01/19/2022 |
4
| Davis Jefferson E (Chief Business Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.21, valued at
$55.3k
|
|
| 01/19/2022 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 18,500 options to buy
@ $2.21, valued at
$40.9k
|
|
| 01/19/2022 |
4
| Amello Jason (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 18,500 options to buy
@ $2.21, valued at
$40.9k
|
|
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Seibt Matthew (Chief Commercial Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.85, valued at
$77k
|
|
| 01/20/2021 |
4
| Schelling Chris (President & CEO) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.85, valued at
$154k
|
|
| 01/20/2021 |
4
| PALMIN HARRY S (Chief Opp. and Financial Offr) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 60,000 options to buy
@ $3.85, valued at
$231k
|
|
| 01/20/2021 |
4
| Klopp John Michael (Chief Technical Officer) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.85, valued at
$77k
|
|
| 01/20/2021 |
4
| Joseph Donald (Chief Legal Officer and Secy) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 60,000 options to buy
@ $3.85, valued at
$231k
|
|
| 01/20/2021 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $3.85, valued at
$57.8k
|
|
|
|
|